Methylene Blue vs Pramiracetam for focus
Short answer: For focus, more users report improvement with Methylene Blue — 100% of 23 reports, versus 95% of 91 for Pramiracetam.
Methylene Blue has 131 meta-analyses and 382 randomized trials on PubMed; Pramiracetam has 0 and 3.
Based on 132 reports about Methylene Blue and 343 about Pramiracetam. Not medical advice.
| Methylene Blue Substance | Pramiracetam Supplement | |
|---|---|---|
| Users say it helped | 64%helped37 reports · medium confidence | 59%helped127 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | AResearch: Strong | CResearch: Limited |
| Meta-analyses / RCTs | 131 / 382 | 0 / 3 |
| Mainly used for | ||
| Focus % reporting improvement | 100% (23) | 95% (91) |
| Memory % reporting improvement | 100% (4) | 95% (38) |
| Energy % reporting improvement | 95% (22) | 91% (11) |
| Mood % reporting improvement | 100% (7) | 45% (22) |
| Anxiety % reporting improvement | 100% (3) | 100% (8) |
| Common side effects | green urine, color change, agitation, serotonin syndrome | headache, emotional blunting, fatigue, bad taste |
| Typical dose reported | 0.5-5 mg / daily | 1 teaspoon |
Among critically ill adults with septic shock, based on low-certainty evidence, MB may reduce short-term mortality, duration of vasopressors, and hospital length of stay, with no evidence of increased adverse events. Rigorous randomized trials evaluating the efficacy of MB in septic shock are needed.
Crit Care Explor, 2024 ↗“Seems to be doing something. My Dual N back scores are up. My social anxiety also seems to be getting better. I am taking 60mcg 3x daily approximately every 5 hours.”
“I was very anxious and listless for a while and the substances that helped me the most were Pramiracetam + alpha GPC.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate